Hereditary elliptocytosis is a disorder passed down through families in which the red blood cells are abnormally shaped.
Elliptocytosis - hereditary
Causes, incidence, and risk factors:
Elliptocytosis affects about 1 in every 2,500 people of northern European heritage. It is more common in people of African and Mediterranean descent. You are more likely to develop this condition if someone in your family has had it.
- Shortness of breath
- Yellow skin and eyes (jaundice) - may persist for a long time in a newborn
Signs and tests:
An examination by your health care provider may occasionally show an enlarged spleen .
The following tests may help diagnose the condition:
Bilirubin level may be high.
- Blood smear may show elliptical red blood cells.
Complete blood count (CBC) may show anemia or signs of red blood cell destruction.
- Lactate dehydrogenase level may be high.
- Ultrasound of the gallbladder may show gallstones.
There is no treatment needed for the disorder unless severe anemia or anemia symptoms occur. Surgery to remove the spleen may decrease the rate of red blood cell damage.
Most persons with hereditary elliptocytosis have no problems, and are unaware of their condition.
Elliptocytosis is frequently harmless. In mild cases, fewer than 15% of red blood cells are elliptical-shaped. However, some people may have crises in which the red blood cells rupture, especially if they have a viral infection. Persons with this disease can develop anemia , jaundice , and gallstones .
Calling your health care provider:
Call for an appointment with your health care provider if you have jaundice that doesn't go away or symptoms of anemia or gallstones.
Genetic counseling may be appropriate for persons with a family history of this disease who wish to become parents.
Golan DE. Hemolytic anemias: red cell membrane and metabolic defects. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 165.
|Review Date: 2/5/2010|
Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.